These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34022454)

  • 1. Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis.
    Biewenga M; Verhelst X; Baven-Pronk M; Putter H; van den Berg A; Colle I; Schouten J; Sermon F; Van Steenkiste C; van Vlierberghe H; van der Meer A; van Hoek B;
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1776-1783.e4. PubMed ID: 34022454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study.
    Plagiannakos CG; Hirschfield GM; Lytvyak E; Roberts SB; Ismail M; Gulamhusein AF; Selzner N; Qumosani KM; Worobetz L; Hercun J; Vincent C; Flemming JA; Swain MG; Cheung A; Chen T; Grbic D; Peltekain K; Mason AL; Montano-Loza AJ; Hansen BE;
    J Hepatol; 2024 Aug; 81(2):227-237. PubMed ID: 38527524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
    J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months.
    Pape S; Gevers TJG; Vrolijk JM; van Hoek B; Bouma G; van Nieuwkerk CMJ; Taubert R; Jaeckel E; Manns MP; Papp M; Sipeki N; Stickel F; Efe C; Ozaslan E; Purnak T; Nevens F; Kessener DJN; Kahraman A; Wedemeyer H; Hartl J; Schramm C; Lohse AW; Drenth JPH; Heneghan MA
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1609-1617.e4. PubMed ID: 31715274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis.
    Guedes LR; Cançado GGL; Santos BC; Jacomassi LDS; Nardelli MJ; Osório FMF; Faria LC; Couto CA
    Ann Hepatol; 2024; 29(4):101497. PubMed ID: 38460715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1.
    Biewenga M; Verhelst XPDMJ; Baven-Pronk MAMC; Putter H; van den Berg AP; van Nieuwkerk KCMJ; van Buuren HR; Bouma G; de Boer YS; Simoen C; Colle I; Schouten J; Sermon F; van Steenkiste C; van Vlierberghe H; van der Meer AJ; Nevens F; van Hoek B;
    United European Gastroenterol J; 2021 Jul; 9(6):662-671. PubMed ID: 34165262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes.
    Aljumah AA; Al-Ashgar H; Fallatah H; Albenmousa A
    Ann Hepatol; 2019; 18(3):439-444. PubMed ID: 31040094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.
    Hino T; Kumashiro R; Ide T; Koga Y; Ishii K; Tanaka E; Morita Y; Hisamochi A; Murashima S; Tanaka K; Ogata K; Kuwahara R; Sata M;
    Int J Mol Med; 2003 Jun; 11(6):749-55. PubMed ID: 12736717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis.
    Gerussi A; Halliday N; Saffioti F; Bernasconi DP; Roccarina D; Marshall A; Thorburn D
    Dig Liver Dis; 2020 Jul; 52(7):761-767. PubMed ID: 32473882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis.
    Hanouneh M; Ritchie MM; Ascha M; Ascha MS; Chedid A; Sanguankeo A; Zein NN; Hanouneh IA
    Scand J Gastroenterol; 2019 Jan; 54(1):76-80. PubMed ID: 30650311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome.
    Al-Chalabi T; Underhill JA; Portmann BC; McFarlane IG; Heneghan MA
    Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1389-95; quiz 1287. PubMed ID: 18840547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of poor response to therapy in Autoimmune Hepatitis.
    Muratori P; Lalanne C; Bianchi G; Lenzi M; Muratori L
    Dig Liver Dis; 2016 Sep; 48(9):1078-81. PubMed ID: 27378707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for recurrence of autoimmune hepatitis after liver transplantation.
    Montano-Loza AJ; Mason AL; Ma M; Bastiampillai RJ; Bain VG; Tandon P
    Liver Transpl; 2009 Oct; 15(10):1254-61. PubMed ID: 19790153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Hepatitis: Predictors of Native Liver Survival in Children and Adolescents.
    Porta G; de Carvalho E; Santos JL; Gama J; Bezerra JA;
    J Pediatr; 2021 Feb; 229():95-101.e3. PubMed ID: 33500120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study.
    Ben Merabet Y; Barbe C; Heurgue-Berlot A; Thévenot T; Minello A; Habersetzer F; Samuel D; Bernard-Chabert B; Weil-Verhoeven D; Renard P; Clot H; Di Martino V; Louvet H; Bresson-Hadni S; Thiéfin G
    Dig Dis Sci; 2021 Jun; 66(6):2107-2117. PubMed ID: 32607807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
    Hino-Arinaga T; Ide T; Kuromatsu R; Miyajima I; Ogata K; Kuwahara R; Hisamochi A; Torimura T; Sata M;
    J Gastroenterol; 2012 May; 47(5):569-76. PubMed ID: 22187167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.